The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Insulin acts in hypokalemic periodic paralysis by reducing inward rectifier K current
Abstract
OBJECTIVE: To define how insulin acts in hypokalemic periodic paralysis (HypoPP). BACKGROUND: HypoPP results from point mutations of the skeletal muscle L-type Ca2+ channel. Attacks of flaccid paralysis are associated with hypokalemia and triggered by insulin. A persistent inward current causes depolarization-induced paralysis. The relationships of the Ca2+ channel mutations to the persistent inward current and how insulin triggers paralytic attacks are not yet known. METHODS: Intercostal muscle fibers from HypoPP and normal subjects were studied in vitro at 37 degrees C using two electrodes to determine action potential thresholds and a three-electrode voltage clamp to study membrane currents. RESULTS: HypoPP fibers were depolarized in bathing solution with 4 mM K+. Reducing K+ from 4.0 mM to 2.5 or 1.0 mM depolarized HypoPP fibers but hyperpolarized normal fibers. Adding 12 mU/mL of insulin to bathing fluids increased the depolarization of HypoPP fibers and increased the hyperpolarization of normal fibers. Depolarized HypoPP had increased action potential thresholds. The fraction of excitable muscle fibers decreased with increasing fiber depolarization. Blocking Na+ channels or L-type Ca2+ channels did not prevent depolarization induced by hypokalemia or by insulin. Insulin reduced the conductance of the inward rectifier K+ channel for outward-flowing currents. CONCLUSIONS: Insulin potentiates depolarization of hypokalemic periodic paralysis (HypoPP) fibers by reducing inward rectifier K+ conductance. The Ca2+ mutations in HypoPP indirectly derange membrane excitability by altering the function of other membrane channels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, insulin and catecholamines not only activate Na+, K+-ATPase but may also inhibit inward rectifying K+ (Kir) channels (39).”
From A 10-year analysis of thyrotoxic periodic paralysis in 135 patients: focus on symptomatology and precipitants (2013) · cites this paper as [39]
In the citing paper
“Moreover, insulin and catecholamine not only activate Na+/K+ ATPase but also inhibit Kir channels [17].”
From Thyrotoxic Periodic Paralysis: Clinical Challenges (2014) · cites this paper as [17]
Citations
Cites
Dihydropyridine receptor mutations cause hypokalemic periodic paralysis
Ptáček, L. J. (1994) · Cell · doi:10.1016/0092-8674(94)90135-x · Cited by 426
Voltage-dependent ATP-sensitive potassium channels of skeletal muscle membrane
Spruce, A. E., Standen, N. B., & Stanfield, P. R. (1985) · Nature · doi:10.1038/316736a0 · Cited by 414
A calcium channel mutation causing hypokalemic periodic paralysis
Jurkat‐Rott, K., Lehmann‐Horn, F., Elbaz, A., Heine, R., Gregg, R. G., Hogan, K. J., Powers, P. A., Laple, P., Vale-Santos, J., Weissenbach, J., et al. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.8.1415 · Cited by 315
Fontaine, B., Vale-Santos, J., Jurkat‐Rott, K., Reboul, J., Plassart, E., Rime, C.-S., Elbaz, A., Heine, R., Guimarães, J., Weissenbach, J., et al. (1994) · Nature Genetics · doi:10.1038/ng0394-267 · Cited by 233
Hypokalemic periodic paralysis: In vitro investigation of muscle fiber membrane parameters
Rüdel, R., Lehmann‐Horn, F., Ricker, K., & Küther, G. (1984) · Muscle & Nerve · doi:10.1002/mus.880070205 · Cited by 184
Primary midline developmental field. I. Clinical and epidemiological characteristics
Martínez‐Frías, M. (1995) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320560406 · Cited by 153
Flatman, J. A., & Clausen, T. (1979) · Nature · doi:10.1038/281580a0 · Cited by 122
Ruff, R. L. (1996) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.1996.189000.x · Cited by 116
Self-citationElbaz, A., Vale-Santos, J., Jurkat‐Rott, K., Lapie, P., Ophoff, R. A., Bady, B., Links, T. P., Piussan, C., Vila, A., & Monnier, N. (1995) · Europe PMC (PubMed Central) · Cited by 113
Tricarico, D., Servidei, S., Tonali, P., Jurkat‐Rott, K., & Camerino, D. C. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4552 · Cited by 108
Research works printed but not linked: 5
- Lehmann-Horn F Engel AG Ricker K Rüdel R. The periodic paralyses and paramyotonia congenita. In: Engel AG Franzini-Armstrong C eds. Myology. 2nd ed.New York:McGraw Hill 1994:1303–1334.
- Zierler KL. Increase in resting membrane potential of skeletal muscle produced by insulin. Science 1957;254:866–868.
- Ruff RL. Insulin-induced weakness in hypokalemic myopathy. Ann Neurol 1979;6:139–140.
- Ruff RL. The role of insulin in hypokalemic periodic paralysis: effect of insulin on the skeletal muscle inward rectifier potassium channel. Neurology 1997;48 (suppl 2):A320. Abstract.
- Ruff RL. Insulin potentiates hypokalemic periodic paralysis by reducing inward rectifier K current, not by opening an L-type Ca channel. Neurology 1998;50 (suppl 4):A367. Abstract.
Cited by
Sorted by citations
Plaster, N. M., Tawil, R., Tristani‐Firouzi, M., Canún, S., Bendahhou, S., Tsunoda, A., Donaldson, M. R., Iannaccone, S. T., Brunt, E. R. P., Barohn, R. J., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00342-7 · Cited by 993
Jurkat‐Rott, K., Mitrović, N., Hang, C., Kouzmenkine, A., Iaizzo, P. A., Herzog, J., Lerche, H., Nicole, S., Vale-Santos, J., Chauveau, D., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9549 · Cited by 262
Channelopathies of Skeletal Muscle Excitability
Cannon, S. C. (2015) · Comprehensive physiology · doi:10.1002/cphy.c140062 · Cited by 242
PATHOMECHANISMS IN CHANNELOPATHIES OF SKELETAL MUSCLE AND BRAIN
Cannon, S. C. (2006) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.112815 · Cited by 210
Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis
Matthews, E., Labrum, R., Sweeney, M. G., Sud, R., Haworth, A., Chinnery, P. F., Meola, G., Schorge, S., Kullmann, D. M., Davis, M. B., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000342387.65477.46 · Cited by 201
Kim, J.-B. (2014) · Korean Journal of Pediatrics · doi:10.3345/kjp.2014.57.1.1 · Cited by 209
Mechanism of Thyrotoxic Periodic Paralysis
Lin, S.-H., & Huang, C.-L. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012010046 · Cited by 174
Jurkat‐Rott, K., Weber, M. D., Fauler, M., Guo, X.-H., Holzherr, B. D., Paczulla, A., Nordsborg, N. B., Jöechle, W., & Lehmann‐Horn, F. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811277106 · Cited by 172
Sodium channelopathies of skeletal muscle result from gain or loss of function
Jurkat‐Rott, K., Holzherr, B. D., Fauler, M., & Lehmann‐Horn, F. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0814-4 · Cited by 154
Sodium Channelopathies of Skeletal Muscle
Cannon, S. C. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_52 · Cited by 142
Skeletal muscle channelopathies
Jurkat‐Rott, K., Lerche, H., & Lehmann‐Horn, F. (2002) · Journal of Neurology · doi:10.1007/s00415-002-0871-5 · Cited by 128
Voltage-sensor mutations in channelopathies of skeletal muscle
Cannon, S. C. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.186874 · Cited by 116
Chang, C.-C., Cheng, C.-J., Sung, C.-C., Chiueh, T.-S., Lee, C.-H., Chau, T., & Lin, S.-H. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0381 · Cited by 114
A calcium channel mutant mouse model of hypokalemic periodic paralysis
Wu, F., Mi, W., Hernández‐Ochoa, E. O., Burns, D. K., Fu, Y., Gray, H. F., Struyk, A. F., Schneider, M. F., & Cannon, S. C. (2012) · Journal of Clinical Investigation · doi:10.1172/jci66091 · Cited by 103
Fontaine, B. (2008) · Advances in genetics · doi:10.1016/s0065-2660(08)01001-8 · Cited by 103
Struyk, A. F., Scoggan, K. A., Bulman, D. E., & Cannon, S. C. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08610.2000 · Cited by 94
Muscle channelopathies and critical points in functional and genetic studies
Jurkat‐Rott, K. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25525 · Cited by 92
Thyrotoxic Periodic Paralysis: Clinical Challenges
Vijayakumar, A., Ashwath, G., & Thimmappa, D. (2014) · Journal of Thyroid Research · doi:10.1155/2014/649502 · Cited by 88
“Hindawi Publishing Corporation Journal of yroid Research Volume 2014, Article ID 649502, 6 pages http://dx.doi.org/10.1155/2014/649502”
InfluentialRetractedNovel etiopathophysiological aspects of thyrotoxic periodic paralysis
Maciel, R. M. B., Lindsey, S. C., & Dias da Silva, M. R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.58 · Cited by 86
An expanding view for the molecular basis of familial periodic paralysis
Cannon, S. C. (2002) · Neuromuscular Disorders · doi:10.1016/s0960-8966(02)00007-x · Cited by 83
KATPchannels depress force by reducing action potential amplitude in mouse EDL and soleus muscle
Gong, B., Legault, D., Miki, T., Seino, S., & Renaud, J. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00278.2003 · Cited by 80
Struyk, A. F., Markin, V. S., Francis, D., & Cannon, S. C. (2008) · The Journal of General Physiology · doi:10.1085/jgp.200809967 · Cited by 79
Struyk, A. F., & Cannon, S. C. (2007) · Muscle & Nerve · doi:10.1002/mus.20928 · Cited by 78
Familial Alzheimer's disease: Site of mutation influences clinical phenotype
Lippa, C. F., Swearer, J. M., Kane, K., Nochlin, D., Bird, T. D., Ghetti, B. F., Nee, L. E., George‐Hyslop, P. S., Pollen, D. A., & Drachman, D. A. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200009)48:3 · Cited by 67
Thyrotoxic periodic paralysis: clinical and molecular aspects
Falhammar, H., Thorén, M., & Calissendorff, J. (2012) · Endocrine · doi:10.1007/s12020-012-9777-x · Cited by 74
Gong, B., Miki, T., Seino, S., & Renaud, J. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.279.5.c1351 · Cited by 74
Pathophysiological Role of Omega Pore Current in Channelopathies
Jurkat‐Rott, K., Groome, J. R., & Lehmann‐Horn, F. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00112 · Cited by 71
Bendahhou, S., Cummins, T., Griggs, R. C., Fu, Y., & Ptáček, L. J. (2001) · Annals of Neurology · doi:10.1002/ana.1144 · Cited by 70
Cheng, C.-J., Lin, S.-H., Lo, Y.-F., Yang, S.-S., Hsu, Y.-J., Cannon, S. C., & Huang, C.-L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.a111.249656 · Cited by 6
Matthews, E. L., & Hanna, M. G. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2009.186627 · Cited by 64
Diagnostics and therapy of muscle channelopathies--Guidelines of the Ulm Muscle Centre.
Lehmann‐Horn, F., Jurkat‐Rott, K., & Rüdel, R. (2008) · PubMed Central · Cited by 55
Periodic paralysis: Understanding channelopathies
Lehmann‐Horn, F., Jurkat‐Rott, K., & Rüdel, R. (2002) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-002-0055-9 · Cited by 54
Hiddemann, W., Kreutzmann, H., Straíf, K., Ludwig, W. D., Mertelsmann, R. H., Planker, M., Donhuijsen‐Ant, R., Lengfelder, E., Arlin, Z. A., & Büchner, T. (1987) · PubMed · Cited by 51
Disorders of Potassium Balance
Mount, D. B., & Zandi‐Nejad, K. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10017-x · Cited by 45
Neurological potassium channelopathies
Benatar, M. G. (2000) · QJM · doi:10.1093/qjmed/93.12.787 · Cited by 44
Tricarico, D., & Camerino, D. C. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00008 · Cited by 43
Transient compartment-like syndrome and normokalaemic periodic paralysis due to a Cav1.1 mutation
Fan, C., Lehmann‐Horn, F., Weber, M. D., Bednarz, M. J., Groome, J. R., Jonsson, M. K. B., & Jurkat‐Rott, K. (2013) · Brain · doi:10.1093/brain/awt300 · Cited by 42
Hypokalemic periodic paralysis; two different genes responsible for similar clinical manifestations
Kim, H., Hwang, H. Y., Cheong, H. I., & Park, H. W. (2011) · Korean Journal of Pediatrics · doi:10.3345/kjp.2011.54.11.473 · Cited by 41
Paroxysmal muscle weakness - the familial periodic paralyses
Jurkat‐Rott, K., & Lehmann‐Horn, F. (2006) · Journal of Neurology · doi:10.1007/s00415-006-0339-0 · Cited by 40
Dias-da-Silva, M. R., Chiamolera, M. I., Kasamatsu, T. S., Cerutti, J. M., & Maciel, R. M. B. (2004) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302004000100022 · Cited by 39
A literature review on thyrotoxic periodic paralysis
Iqbal, Q. Z., Niazi, M., Zia, Z., & Sattar, S. B. A. (2020) · Cureus · doi:10.7759/cureus.10108 · Cited by 33
Wu, F., Quiñonez, M., DiFranco, M., & Cannon, S. C. (2018) · The Journal of General Physiology · doi:10.1085/jgp.201711962 · Cited by 33
INa and IKir are reduced in Type 1 hypokalemic and thyrotoxic periodic paralysis
Puwanant, A., & Ruff, R. L. (2010) · Muscle & Nerve · doi:10.1002/mus.21693 · Cited by 32
Self-citationHypokalemic Periodic Paralysis: A Model for a Clinical and Research Approach to a Rare Disorder
Fontaine, B., Fournier, E., Sternberg, D., Vicart, S., & Tabti, N. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2007.01.002 · Cited by 32
Hypokalemia, muscle weakness, and recumbency in dairy cattle.
Peek, S. F., Divers, T. J., Guard, C. L., Rath, A., & Rebhun, W. C. (2000) · PubMed · Cited by 30
The skeletal muscle channelopathies: basic science, clinical genetics and treatment
Davies, N. P., & Hanna, M. G. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200110000-00001 · Cited by 30
Fuster, C., Perrot, J., Berthier, C., Jacquemond, V., & Allard, B. (2017) · The Journal of Physiology · doi:10.1113/jp274638 · Cited by 30
Timerga, A., Kelta, E., Kenenisa, C., Zawdie, B., Habte, A., & Haile, K. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241486 · Cited by 34
Treatment of Neuromuscular Channelopathies: Current Concepts and Future Prospects
Cleland, J. C., & Griggs, R. C. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.09.001 · Cited by 29
Arimura, K., Arimura, Y., Ng, A. R., Sakoda, S., & Higuchi, I. (2007) · Muscle & Nerve · doi:10.1002/mus.20865 · Cited by 29
Skeletal muscle Na+ channel disorders
Simkin, D. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00063 · Cited by 30
Kostera‐Pruszczyk, A., Potulska‐Chromik, A., Pruszczyk, P., Bieganowska, K. D., Miszczak‐Knecht, M., Bienias, P., Szczałuba, K., Lee, H., Quinn, E. A., Płoski, R., et al. (2014) · Muscle & Nerve · doi:10.1002/mus.24293 · Cited by 26
Acetazolamide-induced Muscle Weakness in Hypokalemic Periodic Paralysis.
Ikeda, K., Iwasaki, Y., Kinoshita, M., Yabuki, D., IGARASHI, O., Ichikawa, Y., & Satoyoshi, E. (2002) · Internal Medicine · doi:10.2169/internalmedicine.41.743 · Cited by 26
Tricarico, D., Montanari, L., & Camerino, D. C. (2003) · Neuromuscular Disorders · doi:10.1016/s0960-8966(03)00095-6 · Cited by 25
Voltage-gated ion channelopathies of the nervous system
Cannon, S. C. (2001) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(00)00011-6 · Cited by 25
PharmGKB summary: very important pharmacogene information for CACNA1S
Sangkuhl, K., Dirksen, R. T., Alvarellos, M. L., Altman, R. B., & Klein, T. E. (2019) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000393 · Cited by 24
Fu, Y., Struyk, A. F., Markin, V. S., & Cannon, S. C. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.199430 · Cited by 21
Reduced expression of Kir6.2/SUR2A subunits explains KATP deficiency in K+-depleted rats
Tricarico, D., Mele, A., Liss, B., Ashcroft, F. M., Lundquist, A. L., Desai, R. R., George, A. L., & Camerino, D. C. (2007) · Neuromuscular Disorders · doi:10.1016/j.nmd.2007.07.009 · Cited by 22
Peripheral channelopathies as targets for potassium channel openers
Lawson, K., & Dunne, M. J. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.7.1345 · Cited by 22
Mechanisms Responsible for ω -Pore Currents in Ca v Calcium Channel Voltage-Sensing Domains
Monteleone, S., Lieb, A., Pinggera, A., Negro, G., Fuchs, J. E., Hofer, F., Striessnig, J., Tuluc, P., & Liedl, K. R. (2017) · Biophysical Journal · doi:10.1016/j.bpj.2017.08.010 · Cited by 21
Genetic disorders of neuromuscular ion channels
Kleopa, K. A., & Barchi, R. L. (2002) · Muscle & Nerve · doi:10.1002/mus.10164 · Cited by 20
Jurkat‐Rott, K., & Lehmann‐Horn, F. (2007) · The Journal of General Physiology · doi:10.1085/jgp.200709834 · Cited by 19
Skeletal muscle sodium current is reduced in hypokalemic periodic paralysis
Ruff, R. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.170293197 · Cited by 19
Self-citationSiddamreddy, S., & Dandu, V. (2021) · StatPearls · Cited by 18
Steroid-induced hypokalemic periodic paralysis: a case report and literature review
Tai, H.-T., Lee, P., & Ou, S. (2023) · BMC Nephrology · doi:10.1186/s12882-023-03131-3 · Cited by 17
Fifty years of gating currents and channel gating
Catacuzzeno, L., Conti, F., & Franciolini, F. (2023) · The Journal of General Physiology · doi:10.1085/jgp.202313380 · Cited by 17
Ruff, R. L., & Shapiro, B. E. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6567-6_53 · Cited by 16
Self-citationChu, P.-Y., Cheng, C.-J., Tseng, M.-H., Yang, S.-S., Chen, H.-C., & Lin, S.-H. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.08.004 · Cited by 14
Welland, N. L., Hæstad, H., Fossmo, H. L., Giltvedt, K., Ørstavik, K., & Nordstrøm, M. (2021) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-200604 · Cited by 14
Kim, J., Kim, S., Kang, S., Yi, J. W., & Kim, S. M. (2014) · Korean Journal of Pediatrics · doi:10.3345/kjp.2014.57.10.445 · Cited by 11
Jin, J., Hu, F., Li, M., Shang, S., Qin, X., Cao, H., & Dang, J. (2017) · Journal of Clinical Neurophysiology · doi:10.1097/wnp.0000000000000405 · Cited by 11
Thyrotoxic periodic paralysis triggered by β2- adrenergic bronchodilators
Yeh, F., Chiang, W., Wang, C.-C., & Lin, S. (2014) · Canadian Journal of Emergency Medicine · doi:10.2310/8000.2013.130867 · Cited by 10
Foppen, R. J. G., & van Heukelom, J. S. (2003) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-003-1042-y · Cited by 10
Allard, B., & Fuster, C. (2018) · The Journal of Physiology · doi:10.1113/jp274955 · Cited by 9
Munir, I., Mehmood, T., Islam, K., Soni, L., & McFarlane, S. I. (2020) · American Journal of Medical Case Reports · doi:10.12691/ajmcr-7-7-5 · Cited by 9
Fialho, D., & Hanna, M. G. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)86004-0 · Cited by 8
Non-dystrophic Myotonias And Periodic Paralyses
Struyk, A. F., & Cannon, S. C. (2005) · Neurological disease and therapy · doi:10.1201/9780849358364.ch9 · Cited by 8
A single-center retrospective study on the clinical features of thyrotoxic periodic paralysis
Yamada, K., Tanabe, A., Hashimoto, M., Ohsugi, M., Ueki, K., & Kajio, H. (2024) · PLoS ONE · doi:10.1371/journal.pone.0308076 · Cited by 7
Wanas, A. M., Giacuzzo, C., Ghazi-Nouri, S., & Tan, L. T. (2025) · Orbit · doi:10.1080/01676830.2023.2296553 · Cited by 6
Paralysie périodique thyréotoxique hypokaliémique : quatre observations et revue de la littérature
Boissier, É., Georgin‐Lavialle, S., Cochereau, D., Ducloux, R., Ranque, B., Aslangul, E., & Pouchot, J. (2013) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2013.03.004 · Cited by 5
An atypical CaV1.1 mutation reveals a common mechanism for hypokalemic periodic paralysis
Cannon, S. C. (2017) · The Journal of General Physiology · doi:10.1085/jgp.201711923 · Cited by 5
Mechanisms underlying the distinct K+ dependencies of periodic paralysis
Foy, B. D., Dupont, C. L., Walker, P. V., Denman, K., Engisch, K. L., & Rich, M. M. (2025) · The Journal of General Physiology · doi:10.1085/jgp.202413610 · Cited by 4
An important piece has been placed in the puzzle of hypokalemic periodic paralysis
Ruff, R. L. (2011) · Neurology · doi:10.1212/wnl.0b013e318219fba9 · Cited by 4
Self-citationThe spectrum of neuromuscular diseases with tubular aggregates
Rashed, H. R., & Selcen, D. (2025) · Neuromuscular Disorders · doi:10.1016/j.nmd.2025.106223 · Cited by 4
Electrophysiology and molecular pharmacology of muscle channelopathies
Jurkat‐Rott, K., & Lehmann‐Horn, F. (2004) · Revue Neurologique · doi:10.1016/s0035-3787(04)71005-x · Cited by 3
Sour on the inside, calm on the outside: How acetazolamide may stabilize membrane excitability
Ruff, R. L. (2006) · Muscle & Nerve · doi:10.1002/mus.20602 · Cited by 3
Self-citationHypokalemia, Muscle Weakness and Recumbency in Dairy Cattle (17 Cases 1991-1998)
Peek, S. F., & Rath, A. (2015) · Cited by 2
Chapter 23 Skeletal muscle channelopathies: myotonias, periodic paralyses and malignant hyperthermia
Lehmann‐Horn, F., Lerche, H., & Jurkat‐Rott, K. (2003) · Handbook of clinical neurophysiology · doi:10.1016/s1567-4231(09)70133-9 · Cited by 2
Calcium Channel Mutations and Associated Diseases
Mori, Y., Itsukaichi, Y., Nishida, M., & Oka, H. (2004) · Springer eBooks · doi:10.1007/978-1-4419-9254-3_9 · Cited by 1
Parálisis periódica hipocalémica familiar (PPHF): reporte de un caso y revisión del tema
Margarita María Vélez, M., Moog, J. C., & Ochoa, J. W. C. (2002) · IATREIA · doi:10.17533/udea.iatreia.3952 · Cited by 1
Teodorescu, G. (2007) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-851 · Cited by 1
Cav1.1 Channel and Hypokalemic Periodic Paralysis
Matthews, E. L., & Hanna, M. G. (2013) · Springer eBooks · doi:10.1007/978-3-642-40282-1_7
Channelopathies; Clinical Manifestations
Puwanant, A., & Griggs, R. C. (2014) · Encyclopedia of the Neurological Sciences · doi:10.1016/b978-0-12-385157-4.00610-2
New territory opened by periodic paralysis associated with mitochondrial DNA mutation
Ruff, R. L., & Cannon, S. C. (2013) · Neurology · doi:10.1212/01.wnl.0000436072.13783.78
Self-citationKim, S., Yoon, D.-H., & Kim, J.-B. (2010) · Journal of Life Science · doi:10.5352/jls.2010.20.3.457
A case of type 2 diabetes manifested by hypokalemic periodic paralysis
Yeom, D. H., Kim, H. Y., Park, B. H., & Cho, C. G. (2009) · The Korean Journal of Internal Medicine
THYROTOXIC PERIODIC PARALYSIS: A CASE REPORT AND REVIEW OF LITERATURE
Choudhuri, R., Adhikari, D., Kar, S. K., & Mitra, S. (2014)
Hypokalemic thyrotoxic periodic paralysis in a young Serbian male
Ristić, P., Dragovic, T., Kikovic, S., Ristić, D., Zdravkovic, M. D., Hinić, S., Durmić, T., & Hajdukovic, Z. (2018) · Vojnosanitetski pregled · doi:10.2298/vsp161130064r
Evaluation of mutant muscle Ca2+ channel properties using two different expression systems
Allard, B. (2018) · The Journal of General Physiology · doi:10.1085/jgp.201812095
Metadata
- Authors
- Ruff, R. L.
- Affiliations
- University Hospitals of Cleveland (US)
- Corresponding author
- Ruff, Robert L.
- ORCID
- Ruff, Robert L.
- Venue
- Neurology
- Published
- 1999-10-22
- Volume
- 53
- Issue
- 7
- Pages
- 1556-1556
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W1967798714
- Cited by
- 112
- References
- 39
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 4 · 2022: 1 · 2021: 4 · 2020: 4 · 2019: 1 · 2018: 4 · 2017: 6 · 2015: 3 · 2014: 7 · 2013: 6 · 2012: 6
- FWCI
- 2.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Nephrology › Potassium and Related Disorders
- Keywords
- hypokalemic periodic paralysis, insulin, inwardly rectifying potassium channels, hypokalemia, action potential threshold, muscle excitability
- MeSH terms
- Adult, Electric Conductivity, Electrophysiology, Extracellular Space, Humans, Insulin, Male, Membrane Potentials, Potassium, Potassium Channels, Muscle Fibers, Skeletal, Hypokalemic Periodic Paralysis, Potassium Channel Blockers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review